Table 1.
Pre and post-operative measurements
| Pre-op (n = 9) | Post-op (n = 9) | P value | |
|---|---|---|---|
| Age (year) | 62.0 (50.5–63.0) | ||
| Male (%,n) | 55.56%, 5 | ||
| Weight (kg) | 127.0 (116.5–144.8) | 100.2 (83.6–110.9) | 0.004 |
| BMI (kg/m2) | 45.5 (42.2–47.8) | 34.3 (29.3–38.3) | 0.008 |
| BSA (m2) | 2.28 (2.18–2.45) | 2.08 (1.97–2.14) | 0.004 |
| Creatinine (μmol/L) | 122.5 (96.8–149.5) | 110.0 (88.0–116.0) | 0.01 |
| Cystatin C(mg/L) | 1.6 (1.3–2.1) | 1.7 (1.4–1.8) | 0.64 |
| EDTA GFR | 58.0 (48.5–91.0) | 59.0 (48.9–72.5) | 0.38 |
| EDTA GFR corrected for BSA (ml/min/1.73 m2) | 43.6 (37.0–65.0) | 45.8 (41.7–63.2) | 0.30 |
| MDRD eGFR (mL/min/1.73m2) | 51.0 (38.3–60.3) | 53.5 (42.3–65.3) | 0.08 |
| CKD Epi (mL/min/1.73m2) | 54.0 (42.0–65.0) | 61.0 (48.5–71.0) | 0.008 |
| CKD Epi cystatin (mL/min/1.73m2) | 39.0 (27.0–49.0) | 40.0 (34.5–49.8) | 1.0 |
| CKD Epi cystatin creatinine (mL/min/1.73m2) | 43.0 (`33.0–56.0) | 47.5 (42.0–54.8) | 0.34 |
| Cockcroft Gauld Creatinine clearance, adjusted (mL/min/1.73 m2) | 77.2 (61.6–89.0) | 75.0 (64.1–92.3) | 0.93 |
Abbreviations: BMI body mass index, BSA body surface area, CKD Epi chronic kidney disease epidemiology collaboration, EDTA ethylenediamine tetraacetic acid, eGFR estimated glomerular filtration rate, MDRD modification of diet in renal disease